Risk Stratification for Bladder Tumor Recurrence, Stage and Grade by Urinary Nuclear Matrix Protein 22 and Cytology Academic Article uri icon

Overview

MeSH Major

  • Biomarkers, Tumor
  • Nuclear Proteins
  • Urinary Bladder Neoplasms

abstract

  • 6.5U/ml is a robust NMP22 cut-point for bladder cancer surveillance. The diagnostic sensitivities of the combined NMP22 and cytology for TCC presence, stage, and grade were significantly higher than those of single marker alone. The combination of urine cytology and NMP22 could be used to tailor the frequency of cystoscopic follow up.

publication date

  • March 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2003.10.020

PubMed ID

  • 15036675

Additional Document Info

start page

  • 304

end page

  • 13; author reply 313

volume

  • 45

number

  • 3